| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.19 | 9e-05 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.18 | 9e-05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.38 | 0.0007 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.15 | 0.0007 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |